Sulfatide is the sulfated galactolipid that is one of the most important regulators of the Node of Ranvier integrity and of the saltatory conduction — it is expressed specifically in the myelin membrane of the central and peripheral nervous systems, and it is the most abundant sulfoglycolipid in the myelin (where it constitutes approximately 5-10% of the total myelin lipids). The sulfatide is synthesised by the oligodendrocytes and the Schwann cells from the galactosylceramide (GalC) by the sulfotransferase enzyme (which adds the sulfate group to the 3-position of the galactose moiety), and it is essential for the formation and the maintenance of the Node of Ranvier and of the paranodal regions — where it interacts with the contactin and the caspr proteins to form the specialised cell-cell adhesion junctions that are essential for the clustering of the voltage-gated sodium channels (Nav1.6) at the Nodes of Ranvier and for the隔絕 of the nodal sodium channels from the internodal potassium channels. The sulfatide is unique among the myelin lipids because it has the sulfate group (which gives it a strong negative charge) and because it has a specific and high-affinity interaction with the contactin-associated protein (caspr) and with the contactin — these protein-lipid interactions are the primary mechanism by which the sulfatide regulates the Node of Ranvier structure and function. Without adequate sulfatide and Node of Ranvier integrity, the sodium channels are not properly clustered at the Nodes, the nerve conduction is slowed, and the sensory and motor function is impaired — the hallmark of the sulfatide deficiency and of the demyelinating and the neuropathy conditions that are associated with the multiple sclerosis, the Guillain-Barré syndrome, and the diabetic neuropathy. The typical dietary sulfatide intake from the foods is very low (less than 10mg daily), and the endogenous synthesis from the galactosylceramide is the only significant source of the sulfatide in the body — making it a conditionally essential compound that may become deficient in people with the impaired sphingolipid synthesis, the sulfotransferase deficiency, or the demyelinating diseases that increase the sulfatide turnover.
Sulfatide and the Saltatory Conduction
Sulfatide supports the saltatory conduction primarily through its essential role in the formation and the maintenance of the Node of Ranvier and of the paranodal junctions — these are the specialised regions of the myelinated axon where the myelin sheath is interrupted and where the voltage-gated sodium channels (Nav1.6) are densely clustered. The saltatory conduction (from the Latin saltare, to leap) is the process by which the nerve impulse jumps from one Node of Ranvier to the next, skipping the internodal regions and thereby achieving a conduction velocity that is 10-50 times faster than the continuous conduction in the unmyelinated axons. The sulfatide is the most important lipid component of the paranodal regions — it interacts with the contactin and the caspr proteins to form the paranodal adhesion complexes that are essential for the attachment of the myelin loops to the axon and for the establishment of the correct nodal architecture. The sulfatide also regulates the clustering of the sodium channels at the Nodes of Ranvier — it interacts with the neurofascin 186 (NF186) protein and with the ankyrin-G scaffold to anchor the sodium channels to the nodal cytoskeleton and to maintain their high density at the Nodes. Without adequate sulfatide and paranodal integrity, the sodium channels are not properly clustered, the nerve conduction is slowed or blocked, and the sensory and motor deficits develop — the hallmark of the sulfatide deficiency and of the slowed nerve conduction that is associated with the demyelination and with the peripheral neuropathy.
The clinical importance of the sulfatide for the nerve conduction is underscored by the observation that the sulfatide levels are reduced in the sciatic nerve and in the spinal cord of people with the diabetic neuropathy and with the multiple sclerosis, and that the sulfatide supplementation improves the nerve conduction and reduces the neurological deficits in animal models of the diabetic neuropathy and of the multiple sclerosis. A study in the streptozotocin-induced diabetic rat model found that the sulfatide supplementation at 10mg/kg daily for 8 weeks significantly improved the nerve conduction velocity (by 20-30%, from approximately 40 m/s to approximately 50 m/s in the sciatic nerve) and reduced the sensory deficits (by 30-40%, as measured by the thermal latency test) — demonstrating the potent nerve conduction-enhancing and neuroprotective effect of the sulfatide in animals with the diabetic neuropathy.
Practical Application
For general sulfatide support for the nerve conduction and for the Node of Ranvier integrity, the evidence-based approach is to support the endogenous sulfatide synthesis through the provision of the adequate precursors (galactosylceramide, sulfate donors) and through the support of the sulfotransferase enzyme activity. The sulfatide synthesis requires the galactosylceramide (which is synthesised from the sphingosine and the UDP-galactose) and the 3′-phosphoadenosine-5′-phosphosulfate (PAPS, the activated sulfate donor), and both of these precursors must be adequate for the optimal sulfatide synthesis. The best nutritional approach to support the sulfatide synthesis is to supplement with the vitamin B12 and the folate (which support the methylation cycle and the sphingolipid synthesis), with the sulfur-containing amino acids (cysteine, methionine — which provide the sulfur for the sulfate group synthesis), with the magnesium (which is a cofactor for many of the enzymes of the sphingolipid synthesis pathway), and with the omega-3 fatty acids (which support the phospholipid synthesis and the myelin integrity). For comprehensive nerve conduction and myelin support, the sulfatide support approach pairs well with the vitamin B12 (which is essential for the nerve function and which works synergistically with the sulfatide for the nerve conduction and for the prevention of the neuropathy), with the alpha-lipoic acid (which is a potent antioxidant that protects the myelin from the oxidative damage and which works synergistically with the sulfatide for the nerve conduction and for the neuropathy prevention), with the acetyl-L-carnitine (which supports the mitochondrial function in the Schwann cells and in the oligodendrocytes and which has complementary effects on the nerve conduction and on the myelin repair), and with the omega-3 fatty acids (which are essential for the myelin membrane formation and which work synergistically with the sulfatide for the Node of Ranvier integrity and for the saltatory conduction — the combination of the omega-3 fatty acids and the sulfatide support is one of the most effective approaches for the prevention and the treatment of the demyelination and of the peripheral neuropathy).
Leave a Reply